Is There a Best First Line Biological/Small Molecule in IBD: Are We Ready for Sequencing?

Is There a Best First Line Biological/Small Molecule in IBD: Are We Ready for Sequencing?

Inflammatory bowel disease (IBD) is a chronic, life-long inflammatory condition of the gastrointestinal tract. Treatment strategy depends on the severity of the disease course. IBD physicians need to be aware of the life-long treatment options available. The goal is not only to achieve clinical remi...

Full description

Bibliographic Details
Main Authors: Gustavo Drügg Hahn, Petra Anna Golovics, Panu Wetwittayakhlang, Alex Al Khoury, Talat Bessissow, Peter Laszlo Lakatos
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Biomedicines
Subjects:
inflammatory bowel disease
biologic therapy
small molecule
biologic-naïve
Online Access:https://www.mdpi.com/2227-9059/10/4/749

Internet

https://www.mdpi.com/2227-9059/10/4/749

Similar Items